Stay updated on ALPN-303 Safety and Tolerability Clinical Trial
Sign up to get notified when there's something new on the ALPN-303 Safety and Tolerability Clinical Trial page.

Latest updates to the ALPN-303 Safety and Tolerability Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- Added a government-operating-status notice and a link to official sources, indicating the page may have dynamic status information. - Updated version from v3.1.0 to v3.2.0, signaling a new release.SummaryDifference5%

- Check32 days agoChange Detected- Added revision: v3.1.0. - Removed topics: MedlinePlus drug safety topics and related MeSH terms (Substandard Drugs, Pharmaceutical Preparations, Counterfeit Drugs) and revision reference v3.0.2. Overall, the page now announces a newer version while narrowing the topic scope slightly.SummaryDifference1%

- Check46 days agoChange DetectedPatch update: the page now shows Revision v3.0.2, replacing v3.0.1. The 'Back to Top' control was removed; no substantive changes to content, pricing, or scheduling were detected.SummaryDifference0.3%

- Check53 days agoChange DetectedThe web page has been updated from version v3.0.0 to v3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.SummaryDifference0.3%

- Check60 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location, while removing specific state, country, and city details. Additionally, it has updated its version from v2.16.12 to v3.0.0.SummaryDifference2%

- Check75 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12, indicating a revision in the content.SummaryDifference0.1%

Stay in the know with updates to ALPN-303 Safety and Tolerability Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALPN-303 Safety and Tolerability Clinical Trial page.